Drug interaction profiling
Dnr:
NAISS 2023/22-1320
Type:
NAISS Small Compute
Principal Investigator:
Ola Spjuth
Affiliation:
Uppsala universitet
Start Date:
2023-12-11
End Date:
2025-01-01
Primary Classification:
30102: Pharmacology and Toxicology
Allocation
Abstract
We perform drug and compound profiling using cheminformatics and cell morphology approaches. The objective is to train models to predict drug profilies, probability of interactions, and safety assessment. Various biological endpoints are targetted.